Angiogenesis in Disease 2.0
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 5436
Special Issue Editors
Interests: bioinorganic chemistry; coordination chemistry; neurochemistry; angiogenesis; metal ions; peptides
Special Issues, Collections and Topics in MDPI journals
Interests: neurochemistry; neurodegeneration; signaling: receptors interactions; receptor metabolism; life/death/differentiation signaling; traslocator protein
Special Issue Information
Dear Colleagues,
Angiogenesis is the physiological process by which new blood capillaries form from the existing vasculature.
Excessive angiogenesis has been implicated, directly or indirectly, in many disorders and among them cancer, autoimmune diseases, diabetic retinopathy, rheumatoid arthritis and atherosclerosis. Conversely, insufficient vascularization and inadequate blood vessel growth can underpin or contribute to cerebral ischemia, coronary heart disease and delayed wound healing.
Angiogenesis is a dynamic and complex process regulated by a very sensitive interplay of different growth factors and inhibitors; the maintenance of their correct balance is essential for the physiological control of blood vessel growth.
The interaction between neoplastic cells and newly formed vessels is one of the fundamental biological events involved in the growth of solid tumor growth and metastases formation. The so-called “angiogenic switch” is an alteration in the balance of pro-angiogenic and anti-angiogenic molecules, with an increase of activators, that can be determined by a local change in the tissue environment, such as hypoxia, low pH, injury, inflammation and metal ions dyshomeostasis.
Angiogenesis is also a prominent feature of brain aging and neurological diseases, either as a pathophysiological factor or as a response to injury. Most cases of Alzheimer’s disease have variable degrees of concomitant vascular pathology, including atherosclerosis, microvascular degeneration, blood–brain barrier dysfunction and cerebral amyloid angiopathy. The increased leakiness in the blood vessels disrupts the blood‐brain barrier and allows unwanted blood products to enter the brain causing the progression of disease pathology and promoting amyloid aggregation. Increased numbers of endothelial cell nuclei and blood vessels have been found postmortem in the substantia nigra of patients affected by Parkinson’s disease.
The interaction between cell growth factors as vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), angiopoietin, platelet derived growth factor (PDGF), epidermal growth factor (EGF), angiogenin and their respective receptors constitutes one of the main targets for the design of new drugs in many pathologies,
As volume 1 of the Special Issue “Angiogenesis in Disease ” has been successful, we will be exploring this issue further in the International Journal of Molecular Sciences (ISSN 1422-0067, IF 5.924, JCR Category Q1). This second Special Issue focuses on the signaling pathways of activators and inhibitors of angiogenesis in pathological conditions as well as to new pharmacological approach based on anti- or pro-angiogenic therapies.
https://www.mdpi.com/journal/ijms/special_issues/Angiogenesis_disease
Dr. Diego La Mendola
Prof. Dr. Claudia Martini
Prof. Dr. Maria Letizia Trincavelli
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- blood vessels
- angiogenic factors
- trophic factors
- angiogenesis biomarkers
- signaling
- cancers
- neurodegeneration
- heart diseases
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
